Attachments
CA231107_Insider trading
Share price & Turnover
+0.66%
|
9774 MDKK
Share price change and turnover during the day of this press release
Calendar
| 2024-11-06 | Quarterly Report 2024-Q3 |
| 2024-08-15 | Ex-date Semi-Annual Dividend NOVO B 3.5 |
| 2024-08-07 | Quarterly Report 2024-Q2 |
| 2024-05-02 | Quarterly Report 2024-Q1 |
| 2024-03-22 | Ex-date Semi-Annual Dividend NOVO B 6.4 |
| 2024-03-21 | Annual General meeting |
| 2024-01-31 | Year-end Report 2023 |
| 2023-11-02 | Quarterly Report 2023-Q3 |
| 2023-09-13 | Split NOVO B 1:2 |
| 2023-08-18 | Ex-date Semi-Annual Dividend NOVO B 6 |
| 2023-08-10 | Quarterly Report 2023-Q2 |
| 2023-05-04 | Quarterly Report 2023-Q1 |
| 2023-03-24 | Ex-date Semi-Annual Dividend NOVO B 8.15 |
| 2023-03-23 | Annual General meeting |
| 2023-02-01 | Year-end Report 2022 |
| 2022-11-02 | Quarterly Report 2022-Q3 |
| 2022-08-12 | Ex-date Semi-Annual Dividend NOVO B 4.25 |
| 2022-08-04 | Quarterly Report 2022-Q2 |
| 2022-05-04 | Quarterly Report 2022-Q1 |
| 2022-03-25 | Ex-date Semi-Annual Dividend NOVO B 6.9 |
| 2022-03-24 | Annual General meeting |
| 2022-02-02 | Year-end Report 2021 |
| 2021-11-03 | Quarterly Report 2021-Q3 |
| 2021-08-16 | Ex-date Semi-Annual Dividend NOVO B 3.5 |
| 2021-08-05 | Quarterly Report 2021-Q2 |
| 2021-05-05 | Quarterly Report 2021-Q1 |
| 2021-03-26 | Ex-date Semi-Annual Dividend NOVO B 5.85 |
| 2021-03-25 | Annual General meeting |
| 2021-02-03 | Year-end Report 2020 |
| 2020-10-30 | Quarterly Report 2020-Q3 |
| 2020-08-14 | Ex-date Semi-Annual Dividend NOVO B 3.25 |
| 2020-08-06 | Quarterly Report 2020-Q2 |
| 2020-05-06 | Quarterly Report 2020-Q1 |
| 2020-03-27 | Ex-date Semi-Annual Dividend NOVO B 5.35 |
| 2020-03-26 | Annual General meeting |
| 2020-02-05 | Year-end Report 2019 |
| 2019-11-01 | Quarterly Report 2019-Q3 |
| 2019-08-21 | Quarterly Report 2019-Q2 |
| 2019-08-16 | Ex-date Semi-Annual Dividend NOVO B 3 |
| 2019-05-03 | Quarterly Report 2019-Q1 |
| 2019-03-22 | Ex-date Semi-Annual Dividend NOVO B 5.15 |
| 2019-03-21 | Annual General meeting |
| 2019-02-01 | Year-end Report 2018 |
| 2018-08-18 | Ex-date Semi-Annual Dividend NOVO B 3 |
| 2018-08-08 | Quarterly Report 2018-Q2 |
| 2018-05-02 | Quarterly Report 2018-Q1 |
| 2018-03-23 | Ex-date Semi-Annual Dividend NOVO B 4.85 |
| 2018-03-22 | Annual General meeting |
| 2018-02-01 | Year-end Report 2017 |
| 2017-11-01 | Quarterly Report 2017-Q3 |
| 2017-08-18 | Ex-date Semi-Annual Dividend NOVO B 3 |
| 2017-08-09 | Quarterly Report 2017-Q2 |
| 2017-05-03 | Quarterly Report 2017-Q1 |
| 2017-03-24 | Ex-date Ordinary Dividend NOVO B 4.60 DKK |
| 2017-03-23 | Annual General meeting |
| 2017-02-02 | Year-end Report 2016 |
| 2016-10-28 | Quarterly Report 2016-Q3 |
| 2016-08-12 | Ex-date Semi-Annual Dividend NOVO B 3 |
| 2016-08-05 | Quarterly Report 2016-Q2 |
| 2016-04-29 | Quarterly Report 2016-Q1 |
| 2016-03-21 | Ex-date Semi-Annual Dividend NOVO B 6.4 |
| 2016-03-18 | Annual General meeting |
| 2016-02-03 | Year-end Report 2015 |
| 2015-10-29 | Quarterly Report 2015-Q3 |
| 2015-08-06 | Quarterly Report 2015-Q2 |
| 2015-04-30 | Quarterly Report 2015-Q1 |
| 2015-03-20 | Ex-date Ordinary Dividend NOVO B 5.00 DKK |
| 2015-03-19 | Annual General meeting |
| 2015-01-30 | Year-end Report 2014 |
| 2014-10-30 | Quarterly Report 2014-Q3 |
| 2014-08-07 | Quarterly Report 2014-Q2 |
| 2014-05-01 | Quarterly Report 2014-Q1 |
| 2014-03-21 | Ex-date Ordinary Dividend NOVO B 4.50 DKK |
| 2014-03-20 | Annual General meeting |
| 2014-02-03 | Year-end Report 2013 |
| 2014-01-02 | Split NOVO B 1:5 |
| 2013-10-31 | Quarterly Report 2013-Q3 |
| 2013-08-08 | Quarterly Report 2013-Q2 |
| 2013-05-01 | Quarterly Report 2013-Q1 |
| 2013-03-21 | Ex-date Ordinary Dividend NOVO B 18.00 DKK |
| 2013-03-20 | Annual General meeting |
| 2013-02-04 | Year-end Report 2012 |
| 2012-10-31 | Quarterly Report 2012-Q3 |
| 2012-08-09 | Quarterly Report 2012-Q2 |
| 2012-04-27 | Quarterly Report 2012-Q1 |
| 2012-03-22 | Ex-date Ordinary Dividend NOVO B 14.00 DKK |
| 2012-03-21 | Annual General meeting |
| 2012-02-02 | Year-end Report 2011 |
| 2011-10-27 | Quarterly Report 2011-Q3 |
| 2011-08-04 | Quarterly Report 2011-Q2 |
| 2011-04-28 | Quarterly Report 2011-Q1 |
| 2011-03-24 | Ex-date Ordinary Dividend NOVO B 10.00 DKK |
| 2011-03-23 | Annual General meeting |
| 2011-02-02 | Year-end Report 2010 |
| 2010-03-25 | Ex-date Ordinary Dividend NOVO B 7.50 DKK |
| 2007-12-03 | Split NOVO B 1:2 |
| 2001-04-04 | Split NOVO B 1:5 |
| 1997-01-02 | Split NOVO B 1:2 |
Description
| Country | Denmark |
|---|---|
| List | Large Cap Copenhagen |
| Sector | Health care |
| Industry | Drugs & Trade |
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
2023-11-07 16:19:36
Bagsværd, Denmark, 7 November 2023 — This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated persons in accordance with Article 19 of Regulation No. 596/2014 on market abuse.
The company’s board members, executives and their associated persons have given Novo Nordisk power of attorney on their behalf to publish trading in Novo Nordisk shares by the company’s board members, executives and their associated persons.
Please find below a statement of such trading in shares issued by Novo Nordisk.
| 1 | Details of the person discharging managerial responsibilities/person closely associated | ||||
| a) | Name of the Board member/Executive/Associated Person | Henrik Wulff | |||
| 2 | Reason for the notification | ||||
| a) | Position/status | Executive Vice President, head of Product Supply, Quality & IT | |||
| b) | Initial notification/Amendment | Initial notification | |||
| 3 | Details of the issuer | ||||
| a) | Name | Novo Nordisk A/S | |||
| b) | LEI | 549300DAQ1CVT6CXN342 | |||
| 4 | Details of the transaction(s) | ||||
| a) | Description of the financial instrument, type of instrument, | Shares | |||
| Identification code | Novo Nordisk B DK0062498333 | ||||
| b) | Nature of the transaction | Sale of shares | |||
| c) | Price(s) and volume(s) | ||||
| Price(s) | Volume(s) | ||||
| DKK 686.03 | 20,000 shares | ||||
| d) | Aggregated information
| 20,000 shares DKK 13,720,600 | |||
| e) | Date of the transaction | 2023-11-06 | |||
| f) | Place of the transaction | Nasdaq Copenhagen | |||
Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat serious chronic diseases, built upon our heritage in diabetes. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure disease. Novo Nordisk employs about 61,400 people in 80 countries and markets its products in around 170 countries. Novo Nordisk's B shares are listed on Nasdaq Copenhagen (Novo-B). Its ADRs are listed on the New York Stock Exchange (NVO). For more information, visit novonordisk.com, Facebook, Instagram, X, LinkedIn and YouTube.
Contacts for further information
| Media: | |
| Ambre James-Brown +45 3079 9289 abmo@novonordisk.com | Elizabeth DeLuca (US) +1 609 580 9868 edel@novonordisk.com |
| Investors: | |
| Daniel Muusmann Bohsen +45 3075 2175 dabo@novonordisk.com | Jacob Martin Wiborg Rode +45 3075 5956 jrde@novonordisk.com |
| David Heiberg Landsted +45 3077 6915 dhel@novonordisk.com | Mark Joseph Root (US) +1 848 213 3219 mjhr@novonordisk.com |
| Sina Meyer +45 3079 6656 azey@novonordisk.com | Frederik Taylor Pitter +45 3075 8259 fptr@novonordisk.com |
Company Announcement No 74 / 2023